- Home
- MLTX vs LADR Comparison
MLTX vs LADR Comparison
Compare MLTX & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | LADR |
|---|---|---|
| Founded | 2021 | 2008 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | MLTX | LADR |
|---|---|---|
| Price | $17.80 | $10.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $27.50 | $12.25 |
| AVG Volume (30 Days) | ★ 901.4K | 699.1K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 8.98% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $31.66 |
| Revenue Next Year | N/A | $16.92 |
| P/E Ratio | ★ N/A | $505.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.95 | $9.61 |
| 52 Week High | $62.75 | $11.92 |
Technical Indicators
Market Signals| Indicator | MLTX | LADR |
|---|---|---|
| Relative Strength Index (RSI) | 48.63 | 56.74 |
| Support Level | $15.89 | $10.16 |
| Resistance Level | $19.24 | $10.54 |
| Average True Range (ATR) | 0.88 | 0.15 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 40.40 | 91.49 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About LADR Ladder Capital Corp
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments: Loans, which derive maximum revenue; Securities; and Real Estate.